The theme COVID-19 now sounds from every iron, and everyone who was a military analyst in January, an economist in the oil industry in February, now suddenly turned into a virologist. Nevertheless, very worthy notes can be distinguished from the information flow. We would like to talk a little about some drugs - and in parallel to touch on the emerging topic of similarity to HIV (there are no similarities), as well as the alleged "anti-HIV drugs work against SARS-CoV-2 coronavirus" ( NO , or at least Not certainly in that way).
Even the notorious Luc Montagnier (Nobel Prize for the discovery of HIV) recently expressed his opinion that the coronavirus SARS-CoV-2 was made artificially, and parts of the HIV genome were used. Most likely, he made this statement because it is believed that SARS-CoV-2 can penetrate the T cells of the immune system, but studies show that there is nothing in common between the genomes of these two viruses.
UFO Care Minute
The pandemic COVID-19, a potentially severe acute respiratory infection caused by the SARS-CoV-2 coronavirus (2019-nCoV), has officially been announced in the world. There is a lot of information on Habré on this topic - always remember that it can be both reliable / useful, and vice versa.
We urge you to be critical of any published information.
Wash your hands, take care of your loved ones, stay at home whenever possible and work remotely.
Read publications about: coronavirus | remote work
Virus
First, a few general words about the virus itself: coronaviruses belong to group IV according to Baltimore’s classification. These are RNA viruses whose genome is directly copied to RNA - this process is called RNA-dependent RNA polymerization, or simply replication.
Replication
, ( ) ( , ). , ( – ), – . -, - – , .
– (remdesivir). , SARS-CoV-2, [2]. () , , . , – , . [3].
, Gilead Sciences, . , , „“, – „“ .
: / , , , (), – () (. – ). – , – .
– „science writer“ , SARS-CoV-2 (AZT = , -). , , ().
: – , . .
– – , , , , . , „“ ( + ) .
– -1 ( , , ). – , „“, . „“ , – , , , .
„“ – , ( ). , . (, , , ..) , .
, , : „“ , . , , . , , ; , , „“. ( – !) . (, ), , ; , , , , ( ) .
: SARS-CoV-2 , – -1, – Asp25 Thr26 Gly27.
, „“ ( , , ) – , , „“ . [4]
. , , SARS-CoV-2
SARS-CoV-2 2 (ACE2) , APN01 ( 2 = hrsACE2), , . , -: („“).
: , , , MERS-CoV (, SARS-CoV-2) , [5]. , , . , .
SARS-CoV-2 - . .
„/ “ , . , ! .
- http://www.leparisien.fr/societe/coronavirus-et-vih-pourquoi-la-theorie-du-pr-luc-montagnier-est-invraisemblable-17-04-2020-8301387.php
- https://edition.cnn.com/2020/04/16/health/coronavirus-remdesivir-trial/index.html
- https://choice.npr.org/index.html?origin=https://www.npr.org/2018/11/27/670913385/ebola-treatment-trials-launched-in-democratic-republic-of-the-congo-amid-outbrea
- https://www.nejm.org/doi/full/10.1056/NEJMoa2001282
- https://www.ncbi.nlm.nih.gov/pubmed/32047128
More on viral infection treatments
- HIV
- Hepatitis C